Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
03/09/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update for Naloxone Product CandidateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/08/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Launch and Marketing Update for SYMJEPINASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/08/201915:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/08/201915:05GlobeNewswire Inc.Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of DirectorsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/08/201917:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/08/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Strengthens Patent Portfolio for its U.S. Compounding SubsidiaryNASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/08/201916:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
08/08/201915:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
08/08/201915:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/08/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/08/201916:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/08/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and WarrantsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/07/201915:05GlobeNewswire Inc.Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/07/201905:03Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
24/07/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on Litigation with Belcher PharmaceuticalsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/07/201912:52GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on Litigation with kaléo Inc.NASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/07/201907:30GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on U.S. Retail Launch of SYMJEPINASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/06/201915:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
11/06/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on Its Higher Dose Naloxone Injection ProductNASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/05/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals to Present at Conferences in June 2019NASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/05/201907:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Patent Litigation Regarding Its Higher Dose Naloxone Injection ProductNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/05/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Conditional Acceptance by FDA of Proprietary Name for Higher Dose Naloxone ProductNASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/05/201915:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces First Quarter 2019 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/05/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/04/201916:02Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/03/201915:39GlobeNewswire Inc.Adamis Pharmaceuticals Announces 2018 Financial Results and Provides Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/03/201915:24Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/03/201915:55Business WireAdamis Pharmaceuticals Announces FDA Acceptance for Review of the New Drug Application of Its Higher Dose Naloxone Injection ...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/03/201915:13Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/02/201917:54GlobeNewswire Inc.Adamis Provides Regulatory Update on Sublingual TadalafilNASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP

Su Consulta Reciente

Delayed Upgrade Clock